Learn About Secondary Systemic Amyloidosis

What is the definition of Secondary Systemic Amyloidosis?

Secondary systemic amyloidosis is a disorder in which abnormal proteins build up in tissues and organs. Clumps of the abnormal proteins are called amyloid deposits.

Secondary means it occurs because of another disease or situation. For example, this condition usually occurs due to long-term (chronic) infection or inflammation. In contrast, primary amyloidosis means there is no other disease that is causing the condition.

Systemic means that the disease affects the entire body.

What are the alternative names for Secondary Systemic Amyloidosis?

Amyloidosis - secondary systemic; AA amyloidosis

What are the causes of Secondary Systemic Amyloidosis?

The exact cause of secondary systemic amyloidosis is unknown. You are more likely to develop secondary systemic amyloidosis if you have a long-term infection or inflammation.

This condition may occur with:

  • Ankylosing spondylitis -- a form of arthritis that mostly affects the bones and joints in the spine
  • Bronchiectasis -- a disease in which the large airways in the lungs are damaged by chronic infection
  • Chronic osteomyelitis -- a long-standing bone infection
  • Cystic fibrosis -- a genetic disease that causes thick, sticky mucus to build up in the lungs, digestive tract, and other areas of the body, leading to chronic infection of the lungs
  • Familial Mediterranean fever -- an inherited disorder of repeated fevers and inflammation that often affects the lining of the abdomen, chest, or joints
  • Gout
  • Hairy cell leukemia -- a type of blood cancer
  • Hodgkin disease -- cancer of the lymph tissue
  • Inflammatory bowel disease
  • Juvenile idiopathic arthritis -- arthritis that affects children
  • Multiple myeloma -- a type of blood cancer
  • Psoriatic arthritis
  • Reactive arthritis -- a group of conditions that causes swelling and inflammation of the joints, eyes, and urinary and genital systems)
  • Rheumatoid arthritis
  • Systemic lupus erythematosus -- an autoimmune disorder
  • Tuberculosis
  • Vasculitis (inflammation of the blood vessels)
What are the symptoms of Secondary Systemic Amyloidosis?

Symptoms of secondary systemic amyloidosis depend on which body tissue is affected by the protein deposits. These deposits damage normal tissues. This may lead to the symptoms or signs of this illness, including:

  • Bleeding in the skin
  • Fatigue
  • Irregular heartbeat
  • Numbness of hands and feet
  • Rash
  • Shortness of breath
  • Swallowing difficulties
  • Swollen arms or legs
  • Swollen tongue
  • Weak hand grip
  • Weight loss
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Secondary Systemic Amyloidosis?

The condition that is causing the amyloidosis should be treated. In some cases, the drug colchicine or an immunosuppressive drug (medicine that suppresses the immune system) is prescribed.

Who are the top Secondary Systemic Amyloidosis Local Doctors?
Advanced in Secondary Systemic Amyloidosis
Hematology Oncology | Hematology | Oncology
Advanced in Secondary Systemic Amyloidosis
Hematology Oncology | Hematology | Oncology

Loyola University Medical Center

2160 S 1st Ave, 
Maywood, IL 
 (159.8 mi)
Languages Spoken:
English
Accepting New Patients

Kevin Barton is a Hematologist Oncology specialist and a Hematologist in Maywood, Illinois. Dr. Barton and is rated as an Advanced provider by MediFind in the treatment of Secondary Systemic Amyloidosis. His top areas of expertise are Shwartzman Phenomenon, Beta Thalassemia, Non-Hodgkin Lymphoma, Aplastic Anemia, and Bone Marrow Aspiration. Dr. Barton is currently accepting new patients.

Advanced in Secondary Systemic Amyloidosis
Hematology Oncology | Hematology | Oncology
Advanced in Secondary Systemic Amyloidosis
Hematology Oncology | Hematology | Oncology
2160 S 1st Ave, 
Maywood, IL 
 (159.8 mi)
Languages Spoken:
English

Agne Paner is a Hematologist Oncology specialist and a Hematologist in Maywood, Illinois. Dr. Paner and is rated as an Advanced provider by MediFind in the treatment of Secondary Systemic Amyloidosis. Her top areas of expertise are Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Thrombocytopenia, and Bone Marrow Aspiration.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Secondary Systemic Amyloidosis
Hematology Oncology | Oncology
Experienced in Secondary Systemic Amyloidosis
Hematology Oncology | Oncology

Carle Health Care Incorporated

611 W Park St, 
Urbana, IL 
 (139.0 mi)
Languages Spoken:
English

James Egner is a Hematologist Oncology specialist and an Oncologist in Urbana, Illinois. Dr. Egner and is rated as an Experienced provider by MediFind in the treatment of Secondary Systemic Amyloidosis. His top areas of expertise are Blood Clots, Monoclonal Gammopathy of Undetermined Significance (MGUS), Lung Adenocarcinoma, and Angiosarcoma.

What is the outlook (prognosis) for Secondary Systemic Amyloidosis?

How well a person does depends on which organs are affected. It also depends on, whether the disease that is causing it can be controlled. If the disease involves the heart and kidneys, it may lead to organ failure and death.

What are the possible complications of Secondary Systemic Amyloidosis?

Health problems that may result from secondary systemic amyloidosis include:

  • Endocrine failure
  • Heart failure
  • Kidney failure
  • Nerve damage
  • Respiratory failure
When should I contact a medical professional for Secondary Systemic Amyloidosis?

Contact your provider if you have symptoms of this condition. The following are serious symptoms that need prompt medical attention:

  • Bleeding
  • Irregular heartbeat
  • Numbness
  • Shortness of breath
  • Swelling
  • Weak grip
How do I prevent Secondary Systemic Amyloidosis?

If you have a disease that is known to increase your risk for this condition, make sure you get it treated. This may help prevent amyloidosis.

What are the latest Secondary Systemic Amyloidosis Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: April 18, 2023
Published By: John Roberts, MD, Professor of Internal Medicine (Medical Oncology), Yale Cancer Center, New Haven, CT. He is board certified in Internal Medicine, Medical Oncology, Pediatrics, Hospice and Palliative Medicine. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Gertz MA. Amyloidosis. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 179.

Papa R, Lachmann HJ. Secondary, AA, amyloidosis. Rheum Dis Clin North Am. 2018;44(4):585-603. PMID: 30274625 pubmed.ncbi.nlm.nih.gov/30274625/.